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Objectives: Hospital readmissions have been an important issue, as they reflect 
suboptimal quality of medical care and incur high health care expenditures. 
However, limited information is available on the patterns of hospital readmission 
in the entire population to support a thorough planning to prevent hospital readmis-
sions. Therefore, this study aimed to examine the patterns and economic burden 
of hospital readmission in Taiwan, and identify predictors of hospital readmis-
sions. MethOds: This study used the National Health Insurance Research Database 
of enrollees randomly selected from those enrolled in the National Health Insurance 
program in 2005. Individuals who were admitted to acute hospitals in 2005 were 
selected and their readmission patterns one-year after discharge were examined. 
Cox proportional hazards regression model was adopted to identify predictors of 
hospital readmission. Results: The 30-day, 6-month and one-year readmission 
rates were 11%, 25%, and 34%, respectively. During the one-year follow-up, 52% of 
total health care expenditures were due to hospital readmissions. Of those who 
were readmitted to hospitals, 56% were readmitted once and took up 29% of the 
cost of rehospitalization. However, those readmitted for more than three times (5%) 
accounted for 30% of the cost. The major disease category of the highest 30-day and 
one-year readmission rates was neoplasms. The disease of the highest 30-day and 
one-year readmission rates were cancer of bronchus and lung (36%) and cancer of 
liver and intrahepatic bile duct (74%), respectively, and the most frequent reason 
for readmission was the disease itself. Age, gender, place of residence, previous 
hospitalization history, comorbidities, and length of stay of the index hospitalization 
were risk factors of hospital readmissions. cOnclusiOns: This study identified 
diseases of higher short-term and long-term readmission rates, causes of short-
term and long-term hospital readmissions, and predictors of hospital readmission. 
The information is of importance for planning interventions to reduce hospital 
readmission rate.
PHP119
secure system for iv administrations: HealtH economic imPact of a 
“smart” infusion safety system
Schmidt A., Bénard S.
st[è]ve consultants, Oullins, France
Objectives: More than half of medication errors are reported during admin-
istration. “Smart” Infusion Safety Systems (SISS) have been developed to avoid 
administration errors and provide data for continuous quality improvement (CQI). 
Few data produced by SISS have been analysed. Given the lack of clinical trials, a 
model was developed in order to assess the economic benefits of SISS from the 
perspective of a French public hospital. MethOds: Comprehensive data from 
6 intensive care units (ICU) were analysed. Two types of alerts were defined: hard 
(absolute) and soft limits. An avoided error was defined as the detection of a 
scheduled infusion over a hard limit or a scheduled infusion over a soft limit that 
was later overridden by staff. The severity of consequences was estimated on 
the HARM INDEX score, which is based on the pharmacologic risk, overdose 
detectability, overdosing range and the type of hospital unit. According to this 
score, errors were categorised as minor, significant, and serious. The economic 
value was estimated based on the hypothetical resulting length of stay had the 
error not been avoided, which increases according to error severity, and the 
financial investment for SISS. Results: Overall, 207,025 infusions were analysed 
from the database of 6 ICUs and 8,503 of them were associated with a safety 
alert (4.1%), including 987 errors (0.48%). Applied to one public ICU equipped with 
5 SISS, the model estimates that SISS would prevent 78 errors per year (54 minor, 
12 significant, 12 serious) and avoid 173 days of hospitalisation per year. This 
corresponds to an annual savings of € 139,491 for the hospital (39% and 61% from 
significant and serious errors, respectively). cOnclusiOns: This model demon-
strates the high economic burden of medication errors for French public hospitals 
and the need for CQI. To date, no equivalent evaluation has been conducted in 
France.
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Objectives: The Human Capital Theory emphasizes investments to the health 
care sector as an important element in achieving and sustaining economic devel-
opment. Investments to health care sector improves macro and micro economic 
outcomes for the whole society. The aim of this study is to calculate the possible 
produced value for a life-time term (VLT) and cost of pre-mature deaths (CPD) 
from the productivity for France, Germany, Italy, Spain, UK (UK). MethOds: Net 
present value (NPV) of the taxes and spending for each year were calculated. For 
calculating NPV in the government perspectives, two modelling approaches were 
combined, human capital modelling based on lives saved and lost productivity, 
and generational accounting, which accounts for a range of other government fis-
cal transfers to citizens. The possible produced value for a life-time term for each 
country were assumed as calculating the total NPV for each country depending 
on the countries life expectancy. CPD for each countries were assumed as the dif-
ference between NPV on the year of life expectancy and each decades as life years 
60, 50, 40, 30, 20, 10. The economic values for the model of each country derived 
from World Bank, OECD, UNESCO or WHO. Results: Possible produced VLT term 
for each country were calculated as US$ 993.347, US$ 629.814, US$ 245.885, US$ 
48.818 and US$ 1.628.957 for France, Germany, Italy, Spain, UK, respectively. CPD per 
person for France were calculated as US$ -1.060.571, US$ -1.148.852, US$ -887.348, 
US$ -551.873, US$ - 224.070 and US$ -10.972 for the life years 10, 20, 30, 40, 50 and 60 
respectively. Although numbers were different, the trend was same for Germany, 
Italy, Spain, UK. cOnclusiOns: However the study was based on a hypothetical 
model that calculated the NPV with the taxes and spending in a life-time term, 
the results of each country were parallel.
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Objectives: Lifelong immunoglobulin G (IgG) replacement is the standard ther-
apy for patients with primary antibody deficiencies. It can be administered either 
intravenously (IVIg) by health care providers in hospital or subcutaneously (SCIg) 
by patients at home. However, self-administration requires patients’ education 
and support over long term to ensure proper adherence and optimal efficacy and 
safety. Every patient who switches to SCIg is proposed by the Policlinique Médicale 
Universitaire (Lausanne, Switzerland) a drug therapy management program with a 
nurse and a community pharmacist including training, coaching and follow-up. 
The aim of the study was to evaluate if switching to SCIg at home including the 
management program was cost-effective compared to IVIg at hospital. MethOds: 
Assuming that both therapies provide similar efficacy, a 3-years cost-minimization 
analysis based on a simulation model was performed from a societal perspective. 
Health care costs (IgG, time of professionals, infusion pumps and disposables) were 
derived from administrative data. Transport and losses of productivity were esti-
mated. One-way sensitivity analyses were performed. Results: Under base case 
assumptions, SCIg at home was estimated at 34960 CHF per patient the first year 
and 30 030 CHF in subsequent years against 34 170 CHF per year for IVIg. The total 
savings for a switch to SCIg at home with the program was 7490 CHF per patient over 
3 years. Results were relatively sensible to the assumptions. cOnclusiOns: Home-
based SCIg therapy including an interprofessional therapy management program 
may be an effective and efficient alternative to hospital for patients with primary 
antibody deficiencies. Additional costs from purchase of equipment and manage-
ment program in the first year were offset by hospital costs avoided in short term. 
Additional studies are ongoing to analyse the retention in the therapy in medium 
term and the impact on quality of life.
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Objectives: Personalized medicine is currently a popular topic in health care 
debates. Yet, the basic differentiation between females and males is hardly found 
in care delivery/health management programs. This study aimed at elucidating 
the opinion of German Statutory Health Insurance (SHI) managers and internal 
specialists regarding gender-specific care in order to understand their percep-
tions on responsibilities and possible implementation opportunities. MethOds: 
Between April and June 2013, a questionnaire on the implementation of gender 
medicine in the current health care landscape was developed. Based on literature 
review and expert consultations, it included open- and closed-ended questions on 
expectations/prioritization, need for action, and implementation of gender medi-
cine. Forty-eight insurance managers of the largest German SHIs, covering over 
95% of the market, and approximately 16,000 physicians of the German Society 
for Internal Medicine (DGIM) were contacted to complete a web-based survey. 
Descriptive analyses, Chi-square tests, and Pearson correlation coefficient were 
used to investigate the research objective. Results: According to both, insurance 
managers (76%) and physicians (60%), gender-specific care is not sufficiently incor-
porated into standard medical care. Respondents claim the responsibility lies with 
the ministry of health, physicians and medical staff, as well as their associations. 
Specifically, more evidence is needed to incorporate gender aspects in treatment 
guidelines, an idea which is well-supported by insurances (65%) and physicians 
(70%). A top-down approach for implementation is preferred by 65% of insurance 
managers and 50% of physicians, whereas fewer participants encourage bottom-
up mechanisms. cOnclusiOns: German SHIs expect a significant governmental 
influence and/or support of self-governing bodies to achieve an incorporation of 
gender medicine into daily practice. Primary responsibility for the integration of 
gender-specific approaches is perceived to lie with physicians. As soon as critical 
hurdles in the medical field will be removed, the positive perception of both partici-
pating parties can be integrated in the implementation process of gender-medicine.
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Objectives: The Human Capital Theory emphasizes investments to the health 
care sector as an important element in achieving and sustaining economic 
development. Investments to health care sector improves macro and micro eco-
nomic outcomes for the whole society. The aim of this study is to calculate the 
possible produced value for a life-time term (VLT) and cost of pre-mature deaths 
(CPD) from the productivity for Turkey where the life expectancies was noted 75 
years. MethOds: Net present value (NPV) of the taxes and spending for each year 
were calculated. For calculating NPV in the government perspectives, two modeling 
approaches were combined, human capital modeling based on lives saved and lost 
